Brain metastases from breast cancer: Proposition of new prognostic score including molecular subtypes and treatment

Journal of Neuro-Oncology

Volumn 106, Issue 1, 2012, Pages 169-176

  Le Scodan, Romuald ^a   Massard, Christophe ^b   Jouanneau, Ludivine ^a   Coussy, Florence ^a   Gutierrez, Maya ^a   Kirova, Youlia ^a   Lerebours, Florence ^a   Labib, Alain ^a   Mouret Fourme, Emmanuelle ^a  

^a INSTITUT CURIE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Brain metastases; Breast cancer; Prognostic score

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LACTATE DEHYDROGENASE; TRASTUZUMAB;

ADULT; AGE; AGED; ANALYSIS; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CLASSIFICATION; CANCER SURVIVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRANCE; HIGH RISK PATIENT; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERFORMANCE; PHENOTYPE; PROGNOSIS; RECURSIVE PARTITIONING ANALYSIS; SCARFF BLOOM RICHARDSON GRADE; SCORING SYSTEM; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; BREAST NEOPLASMS; DECISION TREES; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; L-LACTATE DEHYDROGENASE; LYMPHOCYTE COUNT; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 83055194664     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0654-x     Document Type: Article

References (48)

1. NU Lin JR Bellon EP Winer 2004 CNS metastases in breast cancer J Clin Oncol 22 3608 3617 15337811 10.1200/JCO.2004.01.175 (Pubitemid 41103668)
2. T Fokstuen N Wilking LE Rutqvist, et al. 2000 Radiation therapy in the management of brain metastases from breast cancer Breast Cancer Res Treat 62 211 216 11072785 10.1023/A:1006486423827 1:STN:280:DC%2BD3M3osFSnug%3D%3D
3. D Khuntia P Brown J Li MP Mehta 2006 Whole-brain radiotherapy in the management of brain metastasis J Clin Oncol 24 1295 1304 16525185 10.1200/JCO.2005.04.6185 1:CAS:528:DC%2BD28XjtlGhtrg%3D (Pubitemid 46622033)
4. S Lentzsch P Reichardt F Weber V Budach B Dorken 1999 Brain metastases in breast cancer: prognostic factors and management Eur J Cancer 35 580 585 10492631 10.1016/S0959-8049(98)00421-3 1:STN:280:DyaK1Mvit1aquw%3D%3D (Pubitemid 29192966)
5. L Gaspar C Scott M Rotman, et al. 1997 Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 745 751 9128946 10.1016/S0360-3016(96)00619-0 1:STN:280:DyaK2s3nsFSmsA%3D%3D (Pubitemid 27181303)
6. R Le Scodan C Massard E Mouret-Fourme, et al. 2007 Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score Int J Radiat Oncol Biol Phys 69 839 845 17544592 10.1016/j.ijrobp.2007.04.024 (Pubitemid 47418410)
7. FJ Lagerwaard PC Levendag PJ Nowak, et al. 1999 Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 43 795 803 10098435 10.1016/S0360-3016(98)00442-8 1:STN:280:DyaK1M7ps1Sksw%3D%3D (Pubitemid 29152652)
8. J Lorenzoni D Devriendt N Massager, et al. 2004 Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems Int J Radiat Oncol Biol Phys 60 218 224 15337559 10.1016/j.ijrobp.2004.02.017 (Pubitemid 39165488)
9. D Rades J Dunst SE Schild 2008 A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases Strahlenther Onkol 184 251 255 18427755 10.1007/s00066-008-1831-5 (Pubitemid 351572841)
10. PW Sperduto B Berkey LE Gaspar M Mehta W Curran 2008 A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database Int J Radiat Oncol Biol Phys 70 510 514 17931798 10.1016/j.ijrobp.2007.06.074
11. E Weltman JV Salvajoli RA Brandt, et al. 2000 Radiosurgery for brain metastases: a score index for predicting prognosis Int J Radiat Oncol Biol Phys 46 1155 1161 10725626 10.1016/S0360-3016(99)00549-0 1:STN:280: DC%2BD3c7ptFOlsQ%3D%3D (Pubitemid 30139425)
12. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
13. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 790 800 19228622 10.1056/NEJMra0801289 1:CAS:528: DC%2BD1MXitFWqs70%3D
14. JC Bendell SM Domchek HJ Burstein, et al. 2003 Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2972 2977 12784331 10.1002/cncr.11436 (Pubitemid 36676250)
15. HJ Burstein G Lieberman DJ Slamon EP Winer P Klein 2005 Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy Ann Oncol 16 1772 1777 16150805 10.1093/annonc/mdi371 1:STN:280:DC%2BD2MrlvFGlsA%3D%3D (Pubitemid 41631239)
16. AJ Clayton S Danson S Jolly, et al. 2004 Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer Br J Cancer 91 639 643 15266327 1:CAS:528:DC%2BD2cXmsVCgs7k%3D (Pubitemid 39141617)
17. Z Gabos R Sinha J Hanson, et al. 2006 Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer J Clin Oncol 24 5658 5663 17102066 10.1200/JCO.2006.07.0250 1:CAS:528:DC%2BD2sXhtVChsrc%3D (Pubitemid 46631306)
18. EE Lower E Glass R Blau S Harman 2009 HER-2/neu expression in primary and metastatic breast cancer Breast Cancer Res Treat 113 301 306 18273700 10.1007/s10549-008-9931-6 1:CAS:528:DC%2BD1MXhsVKntA%3D%3D
19. KD Miller T Weathers LG Haney, et al. 2003 Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival Ann Oncol 14 1072 1077 12853349 10.1093/annonc/mdg300 1:STN:280:DC%2BD3szitlCrtg%3D%3D (Pubitemid 36950171)
20. E Shmueli N Wigler M Inbar 2004 Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment Eur J Cancer 40 379 382 14746856 10.1016/j.ejca.2003.09.018 1:CAS:528: DC%2BD2cXmvFCqtQ%3D%3D (Pubitemid 38121275)
21. K Slimane F Andre S Delaloge, et al. 2004 Risk factors for brain relapse in patients with metastatic breast cancer Ann Oncol 15 1640 1644 15520065 10.1093/annonc/mdh432 1:STN:280:DC%2BD2crkslSksw%3D%3D (Pubitemid 39562604)
22. R Bartsch A Rottenfusser C Wenzel, et al. 2007 Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer J Neurooncol 85 311 317 17557136 10.1007/s11060-007-9420-5 1:CAS:528:DC%2BD2sXhsVygt77E (Pubitemid 350142522)
23. S Dawood K Broglio FJ Esteva, et al. 2008 Defining prognosis for women with breast cancer and CNS metastases by HER2 status Ann Oncol 19 1242 1248 18334512 10.1093/annonc/mdn036 1:STN:280:DC%2BD1cvgvVOkuw%3D%3D (Pubitemid 351911952)
24. AF Eichler I Kuter P Ryan, et al. 2008 Survival in patients with brain metastases from breast cancer: the importance of HER-2 status Cancer 112 2359 2367 18361426 10.1002/cncr.23468 1:CAS:528:DC%2BD1cXnsFGjtbg%3D
25. DG Kirsch CJ Ledezma CS Mathews, et al. 2005 Survival after brain metastases from breast cancer in the trastuzumab era J Clin Oncol 23 2114 2116 15774813 10.1200/JCO.2005.05.249 (Pubitemid 46211402)
26. R Le Scodan E Mouret-Fourme C Massard, et al. 2007 Brain metastases from breast carcinoma: prognostic significance of HER-2 overexpression and effect of trastutuzumab J Clin Oncol Suppl 25 A211
27. ME Melisko M Glantz HS Rugo 2009 New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer Nat Clin Pract Oncol 6 25 33 18936791 10.1038/ncponc1243 1:CAS:528:DC%2BD1cXhsFWkurzJ
28. BB Park JE Uhm EY Cho, et al. 2009 Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes? Cancer Chemother Pharmacol 63 627 633 18553084 10.1007/s00280-008- 0779-6
29. S Dawood K Broglio FJ Esteva, et al. 2009 Survival among women with triple receptor-negative breast cancer and brain metastases Ann Oncol 20 621 627 19150943 10.1093/annonc/mdn682 1:STN:280:DC%2BD1M3jt1eqtA%3D%3D
30. BH Nam SY Kim HS Han, et al. 2008 Breast cancer subtypes and survival in patients with brain metastases Breast Cancer Res 10 20 222 10.1186/bcr1870
31. SL Hines LA Vallow WW Tan, et al. 2008 Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer Ann Oncol 19 1561 1565 18534964 10.1093/annonc/mdn283 1:STN:280:DC%2BD1crjtVWnug%3D%3D
32. ME Melisko DH Moore PK Sneed J De Franco HS Rugo 2008 Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival J Neurooncol 88 359 365 18398574 10.1007/s11060-008- 9578-5
33. P Sneed M Melisko D Moore HS Rugo 2003 Predicting survival in breast cancer patients with brain metastases Proc Am Soc Clin Oncol 22 168
34. M Wronski E Arbit B McCormick 1997 Surgical treatment of 70 patients with brain metastases from breast carcinoma Cancer 80 1746 1754 9351543 10.1002/(SICI)1097-0142(19971101)80:9<1746::AID-CNCR8>3.0.CO;2-C 1:STN:280:DyaK1c%2FhtF2jug%3D%3D (Pubitemid 27475932)
35. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
36. A Ciampi JF Lawless SM McKinney K Singhal 1988 Regression and recursive partition strategies in the analysis of medical survival data J Clin Epidemiol 41 737 748 3418363 10.1016/0895-4356(88)90160-6 1:STN:280:DyaL1czjt1eltg%3D%3D
37. WJ Curran Jr CB Scott J Horton, et al. 1993 Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials J Natl Cancer Inst 85 704 710 8478956 10.1093/jnci/85.9.704 (Pubitemid 23133591)
38. Breiman L (1984) Classification and regression trees. Wadsworth, Belmont
39. TM Therneau PM Grambsch TR Fleming 1990 Martingale-based residuals for survival models Biometrika 77 147 160 10.1093/biomet/77.1.147
40. J Chang GM Clark DC Allred, et al. 2003 Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor Cancer 97 545 553 12548595 10.1002/cncr.11083 (Pubitemid 36125831)
41. J Engel R Eckel U Aydemir, et al. 2003 Determinants and prognoses of locoregional and distant progression in breast cancer Int J Radiat Oncol Biol Phys 55 1186 1195 12654426 10.1016/S0360-3016(02)04476-0 (Pubitemid 36338283)
42. C Nieder MP Mehta 2009 Prognostic indices for brain metastases: usefulness and challenges Radiat Oncol 4 10 19261187 10.1186/1748-717X-4-10
43. L Claude D Perol I Ray-Coquard, et al. 2005 Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma Radiother Oncol 76 334 339 16024123 10.1016/j.radonc.2005.06.004 (Pubitemid 41394285)
44. I Ray-Coquard M Van Glabbeke S Negrier 2000 Lymphopenia as an independent prognostic factor for survival in advanced carcinoma, soft tissue carcinoma and lymphoma [Abstract] Proc Am Soc Clin Oncol 19 2591
45. R Bartsch S Fromm M Rudas, et al. 2006 Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer: a retrospective analysis Radiother Oncol 80 313 317 16959347 10.1016/j.radonc.2006.08.001 (Pubitemid 44419433)
46. H Harputluoglu O Dizdar S Aksoy, et al. 2008 Characteristics of breast cancer patients with central nervous system metastases: a single-center experience J Natl Med Assoc 100 521 526 18507204 (Pubitemid 351717364)
47. LM DeAngelis JY Delattre JB Posner 1989 Radiation-induced dementia in patients cured of brain metastases Neurology 39 789 796 2725874 1:STN:280:DyaL1M3mt1Kisw%3D%3D (Pubitemid 19150153)
48. J Li SM Bentzen M Renschler, et al. 2007 Regression after wholebrain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Clin Oncol 25 1260 1266 17401015 10.1200/JCO.2006.09. 2536 (Pubitemid 46640573)